878 related articles for article (PubMed ID: 34579027)
1. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.
Yang M; Gu Y; Li L; Liu T; Song X; Sun Y; Cao X; Wang B; Jiang K; Cao H
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579027
[TBL] [Abstract][Full Text] [Related]
2. Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis.
Pan Y; Zhang H; Li M; He T; Guo S; Zhu L; Tan J; Wang B
Gut Microbes; 2024; 16(1):2356284. PubMed ID: 38769683
[TBL] [Abstract][Full Text] [Related]
3. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
Van den Bossche L; Hindryckx P; Devisscher L; Devriese S; Van Welden S; Holvoet T; Vilchez-Vargas R; Vital M; Pieper DH; Vanden Bussche J; Vanhaecke L; Van de Wiele T; De Vos M; Laukens D
Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115375
[TBL] [Abstract][Full Text] [Related]
5. Impact of Microbial Metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease.
Banfi D; Moro E; Bosi A; Bistoletti M; Cerantola S; Crema F; Maggi F; Giron MC; Giaroni C; Baj A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562721
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
7. Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation.
Xu M; Cen M; Shen Y; Zhu Y; Cheng F; Tang L; Hu W; Dai N
Dig Dis Sci; 2021 Feb; 66(2):568-576. PubMed ID: 32198567
[TBL] [Abstract][Full Text] [Related]
8. Metagenomic analysis of bile salt biotransformation in the human gut microbiome.
Das P; Marcišauskas S; Ji B; Nielsen J
BMC Genomics; 2019 Jun; 20(1):517. PubMed ID: 31234773
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
10. The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease.
Di Ciaula A; Bonfrate L; Khalil M; Portincasa P
Intern Emerg Med; 2023 Nov; 18(8):2181-2197. PubMed ID: 37515676
[TBL] [Abstract][Full Text] [Related]
11. Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets.
Tie Y; Huang Y; Chen R; Li L; Chen M; Zhang S
Gut Microbes; 2023 Dec; 15(2):2265028. PubMed ID: 37822139
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.
Lavelle A; Sokol H
Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):223-237. PubMed ID: 32076145
[TBL] [Abstract][Full Text] [Related]
13. Diversification of host bile acids by members of the gut microbiota.
Winston JA; Theriot CM
Gut Microbes; 2020; 11(2):158-171. PubMed ID: 31595814
[TBL] [Abstract][Full Text] [Related]
14. Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis.
Wang S; Dong W; Liu L; Xu M; Wang Y; Liu T; Zhang Y; Wang B; Cao H
Mol Carcinog; 2019 Jul; 58(7):1155-1167. PubMed ID: 30828892
[TBL] [Abstract][Full Text] [Related]
15. Grape seed proanthocyanidin improves intestinal inflammation in canine through regulating gut microbiota and bile acid compositions.
Zhang M; Mo R; Wang H; Liu T; Zhang G; Wu Y
FASEB J; 2023 Dec; 37(12):e23285. PubMed ID: 37933950
[TBL] [Abstract][Full Text] [Related]
16. Diet-Microbiota Interactions in Inflammatory Bowel Disease.
Sugihara K; Kamada N
Nutrients; 2021 May; 13(5):. PubMed ID: 34062869
[TBL] [Abstract][Full Text] [Related]
17. Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
Sitkin S; Pokrotnieks J
Dig Dis Sci; 2021 Mar; 66(3):925-927. PubMed ID: 33063190
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
[TBL] [Abstract][Full Text] [Related]
19. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing.
Liu T; Song X; Khan S; Li Y; Guo Z; Li C; Wang S; Dong W; Liu W; Wang B; Cao H
Int J Cancer; 2020 Apr; 146(7):1780-1790. PubMed ID: 31291465
[TBL] [Abstract][Full Text] [Related]
20. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.
Duboc H; Rajca S; Rainteau D; Benarous D; Maubert MA; Quervain E; Thomas G; Barbu V; Humbert L; Despras G; Bridonneau C; Dumetz F; Grill JP; Masliah J; Beaugerie L; Cosnes J; Chazouillères O; Poupon R; Wolf C; Mallet JM; Langella P; Trugnan G; Sokol H; Seksik P
Gut; 2013 Apr; 62(4):531-9. PubMed ID: 22993202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
